肝胆期MR图像上的低信号表现
本文阐述肝胆对比剂在MRI中的药效学原理及肝胆期成像价值,将肝胆期低信号分为弥漫性、区域性和局灶性病变三类,并分析肝实质、胆道或血管来源的病因,强调识别次优低信号肝胆期对肝硬化及肝细胞癌患者评估的重要性,以及低信号对肿瘤侵袭性和预后的提示意义。
要点
- 肝胆期低信号可分为弥漫性、区域性和局灶性三类,分别对应不同病因。
- 识别次优低信号肝胆期对肝硬化及肝细胞癌患者的局灶性病变评估至关重要。
- 低信号可提示肝细胞癌或结直肠转移瘤等恶性肿瘤的侵袭性,可能影响预后。
核心结论
- 理解肝胆对比剂药效学并识别肝胆期低信号的分布模式,有助于准确诊断弥漫性肝病、局灶性肝病变及胆道解剖细节,减少误判。
研究设计与样本
- 本文为综述,旨在帮助放射科医生准确理解肝胆期低信号表现;原文未报告检索范围与纳入文献数量。
关键影像表现/征象
- 正常肝细胞摄取肝胆对比剂后经胆汁排泄,形成独特的肝胆期,可反映肝功能及胆道解剖。
- 肝胆期低信号可源于弥漫性、区域性或多灶性异常,与胆汁排泄相关或不相关。
- 低信号病因可来自肝实质、胆道或血管,或上述因素组合。
- 识别次优低信号肝胆期对肝硬化患者尤其肝细胞癌患者的局灶性病变评估很重要。
临床应用与阅片要点
- 诊断肝脏异常时需结合临床背景及全部MRI序列综合判断,以降低误读风险。
- 识别次优低信号肝胆期有助于肝硬化患者局灶性病变的评估。
- 肝胆期低信号可提示肝细胞癌或结直肠转移瘤的侵袭性,可能影响预后。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hepatobiliary (HB) contrast agents are increasingly valuable diagnostic tools in MRI, offering a wider range of applications as their clinical use expands. Normal hepatocytes take up HB contrast agents, which are subsequently excreted in bile. This property creates a distinct HB phase providing valuable insights into liver function and biliary anatomy. HB contrast agents can assist in diagnosing a broad spectrum of HB diseases ranging from diffuse liver disease to focal hepatic lesions and can delineate anatomic details of the biliary tree. Understanding the pharmacodynamics of HB contrast agents is paramount to their appropriate clinical application and troubleshooting. HB phase hypointensity can arise from various diffuse and focal abnormalities that may or may not be associated with biliary excretion. Hypointensity during the HB phase can be broadly grouped into diffuse hypointensity, regional hypointensity, and focal lesions for better evaluation of the underlying cause. Abnormalities may arise from hepatic parenchymal, biliary, or vascular causes, or a combination thereof in each of the broad groups. Recognition of a suboptimal hypointense HB phase is important in the evaluation of focal lesions in patients with cirrhosis of the liver and particularly in those with hepatocellular carcinoma. Furthermore, hypointensity can also suggest the aggressiveness of malignancies such as hepatocellular carcinoma or colorectal metastases, which may affect the prognosis. It is essential to consider all imaging findings relative to the clinical context and the complete set of the MRI sequences performed for diagnosis of liver abnormalities. This comprehensive approach minimizes the risk of misinterpretation or pitfalls. The authors aim to equip radiologists with key insights for accurately understanding hypointensity in the HB phase, ultimately leading to more accurate diagnoses. ©RSNA, 2025 Supplemental material is available for this article.
引用
- Harper KC, Ronot M, Wells ML, et al. Hypointense Findings on Hepatobiliary Phase MR Images. Radiographics. 2025. PMID: 39883575. doi:10.1148/rg.240090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。